Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PLXP

PLx Pharma (PLXP) Stock Price, News & Analysis

PLx Pharma logo

About PLx Pharma Stock (NASDAQ:PLXP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
3,000 shs
Average Volume
12.96 million shs
Market Capitalization
$603,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

PLx Pharma, Inc. is a late-stage specialty pharmaceutical company, which engages in the development and commercialization of technology platform for approved drugs. It offers PLxGuard delivery system, which uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs with a targeted release to select portions of the gastrointestinal (GI) tract. The company was founded by Ronald R. Zimmerman on November 12, 2002 and is headquartered in Sparta, NJ.

Receive PLXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PLx Pharma and its competitors with MarketBeat's FREE daily newsletter.

PLXP Stock News Headlines

This document could hand you a shot at $915 every single weekend!
Something fascinating happens in the options market when most traders aren't paying attention… While everyone else collects standard daily premiums Monday through Friday... There's a special opportunity to target TRIPLE premiums just for holding positions over the weekend. Think about that... Most traders get one day's worth of premium for their trades. But by entering right before the weekend, when everything works out, you could collect THREE days worth - even though markets are closed for two of them. Thanks to a special discovery by a Wall Street legend who helped manage a $1.7 trillion firm – regular folks like you can now target extra cash from the markets on weekends… Just like he showed his small group of traders on December 20th with KO... A quick 2-minute setup Friday afternoon… Head out for the weekend... Monday morning? An extra $1,111 sitting in the account (with a $5k starting stake).
PLXp/USD - Pullix US Dollar
Protalix Biotherapeutics Inc (PLX)
Vertex Pharmaceuticals Inc VRTX
Vietnam National Petroleum Group (PLX)
PLx Pharma Inc (PLXPQ)
See More Headlines

PLXP Stock Analysis - Frequently Asked Questions

PLx Pharma Inc. (NASDAQ:PLXP) issued its quarterly earnings results on Friday, November, 12th. The biotechnology company reported ($0.37) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.46) by $0.09. The business's revenue was up 560.0% on a year-over-year basis.

PLx Pharma (PLXP) raised $68 million in an initial public offering (IPO) on Thursday, February 4th 2016. The company issued 3,800,000 shares at $17.00-$19.00 per share. Raymond James served as the underwriter for the IPO and Maxim Group LLC and Janney Montgomery Scott were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that PLx Pharma investors own include Sorrento Therapeutics (SRNE), Ford Motor (F), SCYNEXIS (SCYX), CymaBay Therapeutics (CBAY), Energy Transfer (ET), Meta Platforms (META) and Pfizer (PFE).

Company Calendar

Last Earnings
11/12/2021
Today
5/31/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:PLXP
Employees
16
Year Founded
2002

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$46.13 million
Net Margins
-606.91%
Pretax Margin
-606.91%

Debt

Sales & Book Value

Annual Sales
$4.54 million
Price / Cash Flow
N/A
Book Value
$1.30 per share
Price / Book
N/A

Miscellaneous

Free Float
26,530,000
Market Cap
$603,000.00
Optionable
Not Optionable
Beta
3.79

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:PLXP) was last updated on 5/31/2025 by MarketBeat.com Staff
From Our Partners